| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.751 | 6.473 | 9.978 | 10.697 | 11.370 | 18.393 | 21.112 |
| Total Income - EUR | - | - | - | 1.824 | 6.713 | 9.730 | 10.721 | 11.504 | 18.394 | 21.113 |
| Total Expenses - EUR | - | - | - | 876 | 5.033 | 5.450 | 6.352 | 5.700 | 11.599 | 9.698 |
| Gross Profit/Loss - EUR | - | - | - | 949 | 1.679 | 4.280 | 4.369 | 5.804 | 6.795 | 11.414 |
| Net Profit/Loss - EUR | - | - | - | 896 | 1.499 | 3.934 | 4.047 | 5.459 | 5.729 | 9.588 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Dumisaftlegdoc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 51 | 30 | 8 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.053 | 3.449 | 6.983 | 14.229 | 15.758 | 20.435 | 31.308 |
| Inventories | - | - | - | 469 | 562 | 592 | 703 | 1.368 | 1.995 | 2.658 |
| Receivables | - | - | - | 0 | 116 | 0 | 6.367 | 1.814 | 1.829 | 1.806 |
| Cash | - | - | - | 1.584 | 2.771 | 6.391 | 7.159 | 12.576 | 16.612 | 26.844 |
| Shareholders Funds | - | - | - | 939 | 2.420 | 6.307 | 10.215 | 5.500 | 11.212 | 20.738 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.165 | 1.059 | 684 | 4.014 | 10.259 | 9.223 | 10.570 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2823 - 2823" | |||||||||
| CAEN Financial Year |
3299
|
|||||||||
Comments - Dumisaftlegdoc S.r.l.